“The Microbiome will be as big as Biotech in 10 Years”
Isabelle de Cremoux, the CEO of Seventure Partners, was at Labiotech Refresh to tell us…
The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing.
Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.
Beyond the Gut: An Atlas of the Human Microbiome
This report discusses the role of the gut and blood microbiomes in different diseases and how they can be used for biomarker discovery and for the development of therapeutics.
Go to ReportIsabelle de Cremoux, the CEO of Seventure Partners, was at Labiotech Refresh to tell us…
Isabelle De Cremoux is the CEO and President of French VC fund Seventure Partners, famous…
Joana Ricou has been dwelling on the frontier of biology and science since she enrolled…
MaaT Pharma (France) has raised €10M in a series A round, which will allow it…
Bento Bio is a London SynBio start-up founded around the Bento Lab; designed to include all…
Research at the University of Lyon (France) and Czech Academy of Sciences have found a…
Have you ever heard of 4D pharma (UK)? Well, it's become one of the biggest and…
We met Pierre Belichard, the CEO of Enterome, last week to discuss the increasingly famous…
As reported in Nature, new data has completely contradicted the universally accepted rule than the…
Microbiomics is a hot area for biotech. Now US Seres Therapeutics and Nestlé Health Sciences…
The Janssen Human Microbiome Institute, the French National Institute for Agricultural Research (INRA) and Johnson…
The French VC firm Seventure's Health for Life Capital investment fund for Microbiome and Biotech…